Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis

Endocrinology

Volumn 143, Issue 10, 2002, Pages 4139-4142

  Ramsey, Melinda M ^a   Ingram, Rhonda L ^a   Cashion, Adrienne B ^b   Amy, H N G ^a   Mark Cline, J ^a   Parlow, A F ^b   Sonntag, William E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; GROWTH HORMONE; SODIUM CHLORIDE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESISTANCE; DOSE RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HETEROZYGOSITY; LIFESPAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; DWARFISM; FEMALE; GROWTH HORMONE; HETEROZYGOTE; IMMUNITY, NATURAL; INSULIN-LIKE GROWTH FACTOR I; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED LEW; REFERENCE VALUES;

EID: 0036773552     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220717     Document Type: Article

References (23)

1. Kenyon C 2001 A conserved regulatory system for aging. Cell 105:165-8.
2. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE 2001 Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. PNAS 98:6736-6741.
3. Bartke A, Brown-Borg H, Mattison J, Kinney B, Hauck S, Wright C 2001 Prolonged longevity of hypopituitary dwarf mice. Experimental Gerontology 36:21-28.
4. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A 2001 Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med 226:552-558.
5. Werner H, Le Roith D 1996 The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68:183-223.
6. Carter CS, Ramsey MM, Sonntag WE 2002 A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet 18:295-301.
7. Sonntag WE, Lenham JE, Ingram RL 1992 Effects of aging and dietary restriction on tissue protein synthesis: Relationship to plasma insulin-like growth factor-1. J Gerontol 47;B1:59-63.
8. Khandwala HM, McCuteheon IE, Flyvbjerg A, Friend KE. 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244.
9. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga, R, Glazer PM 1997 Insulin-like growth factor-1 receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-3083.
10. Steger RW, Bartke A, Cecim M 1993 Premature ageing in transgenic mice expressing different growth hormone genes. J Reprod Fertil Suppl. (England) 46:61-75
11. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D 2002 Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62:1030-1035.
12. Satyamoorthy K, Li G, Vaidya B, Kalabis J, Herlyn M 2002 Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Diff 13:87-93.
13. Qiang YW, Kopantzev E, Rudikoff S 2002 Insulinlike growth factor-I signaling in multiple myeloma: Downstream elements, functional correlates, and pathway cross-talk. Blood 99:4138-46.
14. Stull MA, Richert MM, Loladze AV, Wood TL 2002 Requirement for IGF-1 in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 143:1872-1879.
15. Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB 1996 Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem. 271:29483-29488.
16. Bermont L, Lamielle F, Fauconnet S, Esumi H, Weisz A, Adessi GL 2000 Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. Int J Cancer 85:117-123.
17. Jiang F, Frederick TJ, Wood TL 2001 IGF-1 synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle. Dev Biol 232:414-23.
18. Beierle EA, Strande LF, Chen MK 2002 Insulin-like growth factor-1 protects against starvation-induced apoptosis and is associated with increased Bcl-2 expression. J Pediatr Surg 37:472-6.
19. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R 1992 Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 12:3883-3889.
20. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC 1997 Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667-4672.
21. Resnicoff M, Tjuvajev J, Rotman HL, Abraham D, Curtis M, Aiken R, Baserga R 1996 Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA. J Exp Ther Oncol (England) 1:385-389.
22. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R 1994 Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54:4848-50.
23. Mattison JA, Wright JC, Bronson RT, Roth GS, Ingram DK, Bartke A 2000 Studies of aging in Ames dwarf mice: Effects of caloric restriction. J Am Aging Assoc 23:9-16.